- Report
- June 2024
- 195 Pages
Global
From €3755EUR$3,939USD£3,169GBP
- Report
- March 2024
- 199 Pages
Global
From €3755EUR$3,939USD£3,169GBP
- Report
- January 2024
- 150 Pages
Global
From €5671EUR$5,950USD£4,787GBP
- Report
- February 2024
- 175 Pages
Global
From €4766EUR$5,000USD£4,023GBP
- Report
- July 2024
- 194 Pages
Global
From €4718EUR$4,950USD£3,983GBP
- Report
- October 2023
- 150 Pages
Global
From €2382EUR$2,499USD£2,011GBP
- Report
- July 2024
- 150 Pages
Global
From €3574EUR$3,750USD£3,017GBP
- Clinical Trials
- June 2024
- 240 Pages
Global
From €2860EUR$3,000USD£2,414GBP
- Report
- April 2024
- 152 Pages
Global
From €3765EUR$3,950USD£3,178GBP
- Report
- April 2024
- 115 Pages
Global
From €4289EUR$4,500USD£3,621GBP
- Report
- July 2024
- 196 Pages
Global
From €4528EUR$4,750USD£3,822GBP
- Report
- May 2024
- 182 Pages
Global
From €4671EUR$4,900USD£3,942GBP
- Report
- October 2023
- 190 Pages
Global
From €4671EUR$4,900USD£3,942GBP
- Report
- February 2024
- 175 Pages
Global
From €4766EUR$5,000USD£4,023GBP
- Drug Pipelines
- July 2024
- 180 Pages
Global
From €2383EUR$2,500USD£2,011GBP
- Report
- June 2024
- 200 Pages
Global
From €7578EUR$7,950USD£6,396GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1906EUR$2,000USD£1,609GBP
- Report
- February 2024
- 110 Pages
Global
From €4528EUR$4,750USD£3,822GBP
- Report
- March 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,339GBP
- Report
- April 2022
- 191 Pages
Global
From €4337EUR$4,550USD£3,661GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more